Cyclacel

Results: 30



#Item
1Ellenoff Grossman & Schole LLP 2015 Representative Registered Direct Transactions Areas of Practice Include: CORPORATE AND

Ellenoff Grossman & Schole LLP 2015 Representative Registered Direct Transactions Areas of Practice Include: CORPORATE AND

Add to Reading List

Source URL: www.egsllp.com

Language: English - Date: 2016-01-21 10:54:06
2Gastrointestinal Oncology Introduction The Gastrointestinal Oncology Division currently focuses on chemotherapy with or without radiation therapy against gastrointestinal malignancies. We treat many patients practically,

Gastrointestinal Oncology Introduction The Gastrointestinal Oncology Division currently focuses on chemotherapy with or without radiation therapy against gastrointestinal malignancies. We treat many patients practically,

Add to Reading List

Source URL: www.ncc.go.jp

Language: English - Date: 2014-03-30 02:19:49
3PRESS RELEASE PRESS RELEASE ERYTECH announces management change

PRESS RELEASE PRESS RELEASE ERYTECH announces management change

Add to Reading List

Source URL: erytech.com

Language: English - Date: 2015-01-08 01:31:12
4BIOTOPics  DRUG DISCOVERY AND DEVELOPMENT POTENTIALS – PROFILES – PERSPECTIVES Journal of Biotechnology in Berlin-Brandenburg

BIOTOPics DRUG DISCOVERY AND DEVELOPMENT POTENTIALS – PROFILES – PERSPECTIVES Journal of Biotechnology in Berlin-Brandenburg

Add to Reading List

Source URL: www.healthcapital.de

Language: English - Date: 2015-01-20 05:59:14
5The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe

The team at Cerulean (NASDAQ: CERU) is committed to improving treatment for people living with cancer. We apply our Dynamic Tumor Targeting™ Platform to create a portfolio of nanoparticle-drug conjugates (NDCs) designe

Add to Reading List

Source URL: www.ceruleanrx.com

Language: English - Date: 2015-06-01 11:12:23
6June 14, 2013  Astex Pharmaceuticals Announces Presentation of Updated Results of SGI[removed]Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology As

June 14, 2013 Astex Pharmaceuticals Announces Presentation of Updated Results of SGI[removed]Study in Patients With Intermediate or High Risk Relapsed or Refractory Myelodysplastic Syndromes at the European Hematology As

Add to Reading List

Source URL: astx.com

Language: English
7BIOTOPics  DRUG DISCOVERY AND DEVELOPMENT POTENTIALS – PROFILES – PERSPECTIVES Journal of Biotechnology in Berlin-Brandenburg

BIOTOPics DRUG DISCOVERY AND DEVELOPMENT POTENTIALS – PROFILES – PERSPECTIVES Journal of Biotechnology in Berlin-Brandenburg

Add to Reading List

Source URL: www.berlin-partner.de

Language: English - Date: 2015-03-05 07:36:10
8June 13, 2014 To Our Stockholders, At our Annual Meeting of Stockholders held June 12, 2014, EntreMed stockholders voted in favor of changing our company’s corporate name to CASI Pharmaceuticals, Inc. Our name change w

June 13, 2014 To Our Stockholders, At our Annual Meeting of Stockholders held June 12, 2014, EntreMed stockholders voted in favor of changing our company’s corporate name to CASI Pharmaceuticals, Inc. Our name change w

Add to Reading List

Source URL: www.casipharmaceuticals.com

Language: English - Date: 2014-06-15 20:03:50
9No. 43  www.biodundee.co.uk ..................................................................... Life

No. 43 www.biodundee.co.uk ..................................................................... Life

Add to Reading List

Source URL: www.biodundee.co.uk

Language: English
10/P  XXXCJPEVOEFFDPVL  -JGF4DJFODFT/FXTGSPN4DPUMBOET$JUZPG%JTDPWFSZ

/P XXXCJPEVOEFFDPVL  -JGF4DJFODFT/FXTGSPN4DPUMBOET$JUZPG%JTDPWFSZ

Add to Reading List

Source URL: www.biodundee.co.uk

Language: English